Liquid chromatography–tandem mass spectrometry (LC–MS/MS) measures galactose-1-phosphate in dried blood spots to monitor galactosemia.
|Articles|November 1, 2016
- Special Issues-11-01-2016
- Volume 34
- Issue 11
Vol 34 No s11 LCGC North America November 2016 Advances in Biopharmaceutical Analysis Supplement PDF
Click the title above to open the LCGC North America November 2016 Advances in Biopharmaceutical Analysis Supplement, Vol 34 No s11, in an interactive PDF format.
Advertisement
Articles in this issue
about 10 years ago
Advances in Biopharmaceutical Analysisabout 10 years ago
Higher Order Mass Spectrometry Techniques Applied to BiopharmaceuticalsAdvertisement
Related to this article
Sam Whitmarsh explores how retention-time models handle interlaboratory data, novel chemotypes, unusual phases and ionisable compounds, and what labs need to do to build useful in-house models.
Dual-column ultra-high-performance liquid chromatography-mass spectrometry (UHPLC-MS) reveals urine markers of apple intake lasting 24 hours.
Sam Whitmarsh describes a practical workflow for predicting reversed-phase LC retention times using ensemble machine learning and open chromatographic data.
This month's LCGC Blog explores the variety of career options that are open to separation scientists.
Optimized preparation and data-independent acquisition (DIA) liquid chromatography–mass spectrometry (LC-MS) detect up to 6500 proteins in laboratory-grown duck.
Directive (EU) 2024/3019 makes drug manufacturers financially responsible for removing pharmaceutical residues from wastewater and introduces stricter, standardized monitoring requirements that are set to increase demand for trace-level analytical expertise.
Advertisement
Advertisement
Trending on LCGC International
1
New EU Wastewater Rules Put Pharmaceutical Micropollutant Monitoring in the Spotlight
2
AI/ML Now: Predicting Reversed-Phase LC Retention Using Ensemble Machine Learning and Open Chromatographic Data (Part One)
3
AI/ML Now: Predicting Reversed-Phase LC Retention Using Ensemble Machine Learning and Open Chromatographic Data (Part Two)
4
From 9000 Clues to a Clinical Test: Mass Spectrometry-Driven Lipidomics for Early Cancer Detection
5